Previous studies have shown that AMT can be used to treat murine and human HSK, which is a T cell–mediated disease.
7 19 We found that AMT strongly reduced the number of CD3
+ T lymphocytes in the cornea, and increased lymphocyte apoptosis was observed in corneas with HSK and in T cells harvested from these corneas early after AMT. An earlier study reported that AM collected from patients treated with AMT contained varying degrees of inflammatory cells (positively stained with CD14, CD4
−, and CD8) in the AM stroma. Many of these cells also stained positively with TUNEL, suggesting apoptotic cell death.
35 However, the AM collected from HSK mice did not contain significant numbers of inflammatory cells, suggesting that attraction of cells into the AM may not be the main anti-inflammatory mechanism in the HSK model (data not shown). Our findings suggest that soluble factors from the matrix may be responsible for the observed improving effects on ulcerating HSK and for the immune-modulating action on inflammatory cells.
13 36
Apoptosis was also induced by AM in isolated lymphocytes, indicating that the AM interacts directly with these cells and that the presence of corneal tissue, known to express surface molecules such as FasL in healthy corneas, is not essential.
37 Furthermore, these results indicate that lymphocyte apoptosis induced by AM occurs primarily independently of cytokines, thereby excluding passive apoptosis as a result of a lack of IL-2. AICD was excluded as another possibility for lymphocyte apoptosis from AM. For AICD to be induced in nontransformed T lymphocytes, a combination of two mitogenic stimuli at relatively high doses is required, an antigen or mitogen that acts on the T-cell receptor (TCR) and a lymphokine such as IL-2. It was demonstrated that AICD involved induction of the Fas ligand and, thus, induction of Fas-mediated apoptosis. Hence, pharmacologic interference with the IL-2 pathway in activated T cells, such as by the addition of CsA or rapamycin, typically prevented Fas-dependent lymphocyte depletion.
38 39
Treatment with CsA or rapamycin did not protect the lymphocytes against AM-mediated cell death in our experiments. Furthermore, FasL was not induced with AM, and splenocytes from Fas knockout mice (C57lpr) were not resistant to AM-induced apoptosis. Consequently, AM-mediated apoptosis in lymphocytes does not appear to be related to AICD.
Previous studies have shown that the expression of IL-8, Gro-α, and epithelial cell-derived neutrophil attractant (ENA) was suppressed in keratocytes cultured on AM stromal matrix (Bültmann S, et al.
IOVS 1999;40:ARVO Abstract 3044).
6 We observed that CRG-2/IP-10 and CCL-2/MCP-1 levels were significantly lower in the murine corneas with HSK after AMT. IFN-γ–inducible protein 10 (CRG-2/IP10) is a chemokine that preferentially attracts Th1 lymphocytes through its receptor CXCR3, which is expressed at high levels on these cells. This is in agreement with previous observations that the treatment of HSV-1–infected mice with antibody to IP-10 significantly reduced ICAM-1 and CXCR3 transcript expression, MIP-1α and IP-10 levels, and corneal disease.
40 The monocyte chemoattractant protein-1 (CCL-2/MCP-1) plays a crucial role in recruiting monocytes and lymphocytes during inflammatory responses.
41 It has been shown that CCL-2/MCP-1 depletion resulted in innate immune modulation and increased corneal inflammation as a result of MIP-2 overexpression.
42 In fact, we found increased amounts of MIP-2/CXCL2 in murine corneas with HSK and AMT.
24 Neutralizing antibodies to MIP-2 suppressed HSV-1–specific DTH and sharply reduced neutrophil accumulation in the ear pinna.
43
Recently, it has been shown that AM is able to suppress IL-1 mRNA transcription and IL-1 expression in human limbal epithelial cells.
6 In our experiments, we found that the expression of IL-12, a cytokine produced by a variety of immune effector cells and thus leading to a Th1 response in HSK,
44 45 was downregulated in the corneas after AMT. This suggests that, in addition to apoptosis induction, other AM mechanisms are in play and affect lymphocyte activation and influx into the cornea.
Thus, the typical Th1 cytokine IL-2 was found to be suppressed in AMT-treated corneas. In the experimental HSK model, inflammation could be prevented by neutralizing IL-2 or disease remission could be induced. Indeed, neutralizing IL-2 resulted in decreased IFN-γ production, reduced chemotaxis, and loss of PMN viability in the infected cornea.
2 46 47 The fact that the anti-inflammatory cytokine IL-10 was also decreased after AMT in our experiments was unexpected because it was previously reported that IL-10 treatment can prevent HSK from developing and this was associated with reduced chemokine production.
17 48 49 A previous study showed that human AM can suppress alloreactive T-cell synthesis in Th1- and Th2-type cytokines in vitro.
13 Our in vitro experiments showed that AM decreased DLN cell proliferation and production of IFN-γ, IL-2, and IL-10. AM also decreased the activation markers CD25, CD69, and MHC class II on DLN cells 24 hours after HSV-1 antigen- specific and antigen-unspecific activation. However, an increase in CD25
+ and MHC class II+ surface molecules on DLN cells was present after 4 hours. These findings are consistent with the induction of apoptosis, as others have reported that the generation of inflammatory signals can be an intrinsic component of the apoptotic machinery.
50 51
Other studies have shown that apoptosis of lymphocytes can also result in immune tolerance.
52 53 Mechanisms proposed for the tolerogenic nature of apoptosis included deletion of reactive clones,
26 anergy,
54 immune deviation (Th1 to Th2),
55 and active regulation by regulatory T cells.
56
Previously we demonstrated that the immune response in the spleen was not affected 2 days after AMT treatment of mice with HSK.
57 Given that AM may remain for weeks or even months in the clinical setting
19 and given that the systemic immune response against HSV-1 is also important to control virus latency, we determined how long-term AM treatment might affect the immune response in the regional and systemic immune system. Proliferation and IFN-γ and IL-2 secretion in DLN cells was reduced. Results show that even prolonged AMT predominantly affected the regional (Th1) immune responses. These findings could, at least in part, be the result of decreased cytokine secretion (e.g., IL-12) in corneas with HSK after AMT, ultimately decreasing proliferation and Th1-cytokine production in the DLN.
In agreement with our previous data,
57 we found that DTH responses after AMT were comparable with those after tarsorrhaphy. In addition, the in vivo cytotoxicity assay showed no evidence for a HSV-1–specific depletion of splenocytes after AMT from HSV-1–infected mice. Thus, even long-term AMT did not affect immunologic memory against HSV-1. Accordingly, immune-mediated HSK recurred shortly after the end of long-term application of AMT.
We also assessed whether adoptive transfer of AM-induced apoptotic splenocytes could induce signs of tolerance induction or immune suppression. Our observations revealed that a transient reduction in antigen-specific and spontaneous proliferation of DLN or splenocytes was induced, but the HSK lesions had not improved (data not shown). As a consequence, tolerance induction by regulatory cells or by systemic cell depletion does not appear to be the primary mechanism underlying the improvement in HSK after AMT.
We did find some evidence that innate immunity was stimulated (e.g., CXCL2/MIP-2).
24 Given that virus infections are known to elicit immunologic “danger” signals, these signals might prevent the acquisition of long-term tolerance or long-term protection in experimental HSK.
It is critical that apoptotic cells be removed during tissue remodeling or while inflammation is resolving to preserve normal tissue structure and function.
58 Engulfment of apoptotic cells by professional and nonprofessional phagocytes sets up an anti-inflammatory environment within the tissue that is mediated in part by the autocrine/paracrine action of TGF-β.
58 59 Others have found that innate immune responses can also be induced by apoptotic cells, as CXCL2/MIP-2 is secreted from peritoneal macrophages after ingestion of apoptotic T cells that also support leukocyte infiltration to the site of apoptosis in some situations.
60
The mechanism underlying T-cell apoptosis induction by AM is still not known and most likely involves multiple factors from AM.
4 Furthermore, it has been shown that AM can also be antiapoptotic, as in corneal epithelial cells.
61 Diverse cell signals that may originate from extrinsic inducers, such as toxins, hormones, growth factors, nitric oxide, or cytokines, might control apoptosis.
62 63 Alternatively, apoptosis could also be induced by intracellular cell signaling, such as through glycocorticoids, radiation, nutrient deprivation, heat, hypoxia, viral infection, and increased intracellular calcium concentrations.
64 Previously, it was reported that amniotic epithelial cells produce many immunomodulatory factors, including TNF-α, FasL, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TGF-β, macrophage migration-inhibitory factor (MIF), and other factors that may induce apoptosis in T and B cells.
65 Future studies must define the molecules that induce these immune modulatory events after AMT in HSK mice.